by DAVID.KIEWLICH | Sep 11, 2026 | Incubator
Your company just got the best news there is. Your product is working, customers are lining up, the world wants what you’ve built. Now an incubator asks you to leave. “Congratulations. It is time for you to graduate.” Moving a startup is expensive. Moving a biotech...
by DAVID.KIEWLICH | Sep 10, 2026 | Biotech Lab Access
Your data won’t care whether you had unrestricted access to lab equipment. But your ability to generate that data will. In 2026, raising seed and Series A funding is tough. Investors are asking for data. Sometimes even proof-of-concept data at seed stage. And in order...
by DAVID.KIEWLICH | Aug 28, 2026 | Biotech
How many classes in grad school taught you how to set up a cap table? Or how to talk about the difference between a convertible note and a SAFE? Or even what’s required in a pre-submission document? Probably none. Because that’s not what grad school does. There’s a...
by DAVID.KIEWLICH | Aug 28, 2026 | Biotech
You found something new in the lab. Maybe it’s a new cell therapy target, a bio manufacturing process that could drastically reduce the price of a life saving medicine, or a battery material that could completely change how we store electricity. You have the results,...
by DAVID.KIEWLICH | Aug 21, 2026 | Biotech
Dr. David Kiewlich spent 18 months looking for lab space before he could conduct his first experiment as a founder. That’s 18 months of burn rate and no data. He had to go back to investors and ask for more money to get proof of concept data. His company needed...